Video: New Topical Drug Delivery System, NeuroDirect™

Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs. https://youtu.be/2CGT7P9QEvo Can this be used for Ketamine treatments? Time will tell, as they are...

Topical PTSD Drug Poised for Human Trials.

In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid and psychedelic...
Zappy Zapolin, Lamar Odom, Roland Rick Perry

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. Ketamine.

Above: Lamar Odom and Psychedelic Spokesman Mike Zappy Zapolin We're Calling a Sector Bottom, and Psycheceutical (BWVI) as Our Favorite. We launched the Psychedelic Stock Review...

Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment...

Topline Results anticipated by the end of Q2 2023 CRANFORD, N.J. , April 3, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced...

Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update

$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024 Uptick in patient recruitment for Mino-Lok® Phase 3 trial Halo-Lido Phase 2b trial nearing completion CRANFORD,...

Adding Cardiol Therapeutics (CRDL) $0.59 to Watch List.

Adding to 2023 Biotech Stock Review Watch List. We Think This One Has Legs. Starting Due Diligence Now. It takes us about 15 minutes after talking...

Ardelyx (ARDX) Resubmits New Drug Application to FDA.

WALTHAM, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize...
ARDX, Roland Rick Perry

And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.

LIVE QUOTE Ardelyx Enters the Danger Zone* With Tenapanor. The company produced favorable (albeit very technical) information (data) at the National Kidney Foundation 2023 Spring Clinical...
Internet Stock Review, Biotech Stock Review, Roland Rick Perry

Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up 249%.

Stormin..Live Quote We're still not sure how to pronounce it...but Wall Street likes it. News Archive Unicycive Therapeutics (UNCY) $2.73. We're now up 249%. Unicycive (UNCY) Shoots and...

Latest article

Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).

Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data. The press release link below list nearly all of...

Three Stocks Percolating, Up 106%, Up 169%, and up 483%.

Odyssey Marine (OMEX) gained 169% on a 225 million share day from where we added it to 2026 Watch list. Society Pass (SOPA) gained...

Society Pass (SOPA) Gains 55% Post 8K Filing.

AI says: "The Court issued a mixed ruling, rejecting several major claims while upholding earlier awards and ordering rescission of certain agreements, with full...